- MedPharm has secured a commercial manufacturing and supply agreement for a first-to-file generic topical product, adding it to the company’s commercial manufacturing portfolio.
- The agreement marks MedPharm’s sixth commercial deal in 22 months. The product will be manufactured at the company’s 110,000-square-foot commercial facility in Durham, North Carolina.
MedPharm has secured a commercial manufacturing and supply agreement for a first-to-file generic topical product. The company will serve as the product’s commercial manufacturing and supply partner, expanding its portfolio of topical pharmaceutical products.
The agreement represents MedPharm’s sixth commercial deal in the past 22 months. It also marks an expansion into first-to-file generic topical drug products, building on the company’s nearly three decades of experience in topical and transepithelial drug development and manufacturing.
Manufacturing will take place at MedPharm’s 110,000-square-foot commercial facility in Durham, North Carolina. The site combines specialized manufacturing and analytical capabilities, purpose-built infrastructure and an experienced team to support commercial production and supply of topical drug products.
“The agreement reflects the company’s expanding commercial portfolio and its expertise in topical drug products. He added that the team would support its partner through commercial manufacturing and supply.”
Bill Humphries, Chief Executive Officer of MedPharm
